−26.66MXN
−5.10 BMXN
1.38 BMXN
91.60 M
About CUREVAC NV
Sector
CEO
Alexander Zehnder
Headquarters
Tübingen
Website
Employees (FY)
1.05 K
Founded
2020
ISIN
NL0015436031
FIGI
BBG00YM3WXX0
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CVAC/N is 50.00 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange CUREVAC NV stocks are traded under the ticker CVAC/N.
CUREVAC NV is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
CVAC/N stock is 0% volatile and has beta coefficient of 0.55. Check out the list of the most volatile stocks — is CUREVAC NV there?
CVAC/N earnings for the last quarter are −5.61 MXN per share, whereas the estimation was −4.48 MXN resulting in a −25.09% surprise. The estimated earnings for the next quarter are −4.15 MXN per share. See more details about CUREVAC NV earnings.
CUREVAC NV revenue for the last quarter amounts to 141.90 M MXN despite the estimated figure of 385.44 M MXN. In the next quarter revenue is expected to reach 312.74 M MXN.
Yes, you can track CUREVAC NV financials in yearly and quarterly reports right on TradingView.
CVAC/N stock has fallen by 13.79% compared to the previous week, the month change is a 13.79% fall, over the last year CUREVAC NV has showed a 61.24% decrease.
CVAC/N net income for the last quarter is −923.08 M MXN, while the quarter before that showed −1.26 B MXN of net income which accounts for 26.60% change. Track more CUREVAC NV financial stats to get the full picture.
Today CUREVAC NV has the market capitalization of 9.71 B, it has decreased by 1.17% over the last week.
No, CVAC/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CVAC/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CUREVAC NV stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 1.05 K employees. See our rating of the largest employees — is CUREVAC NV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CUREVAC NV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CUREVAC NV stock shows the sell signal. See more of CUREVAC NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CUREVAC NV future price: according to them, CVAC/N price has a max estimate of 352.67 MXN and a min estimate of 50.36 MXN. Read a more detailed CUREVAC NV forecast: see what analysts think of CUREVAC NV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CUREVAC NV EBITDA is −5.36 B MXN, and current EBITDA margin is −384.87%. See more stats in CUREVAC NV financial statements.